News + Filings Transactions Holdings
All 13F 13D/G Other
|
MILLER RICHARD A MD
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/03/2023 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 800,000 options to buy
@ $0.91, valued at
$728k
|
|
12/16/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $1.36, valued at
$34k
|
|
12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/20/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 12,300 shares
@ $0.8101, valued at
$10k
Bought 2,700 shares
@ $0.82, valued at
$2.2k
Bought 5,000 shares
@ $0.815, valued at
$4.1k
|
|
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $1.99, valued at
$49.8k
|
|
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 15,000 shares
@ $1.6356, valued at
$24.5k
|
|
03/28/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
03/17/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 25,000 shares
@ $1.466, valued at
$36.7k
Bought 5,000 shares
@ $1.59, valued at
$8k
|
|
09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2020 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 320,000 options to buy
@ $4.01, valued at
$1.3M
|
|
12/16/2019 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 320,000 options to buy
@ $3.54, valued at
$1.1M
|
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2019 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 343 shares
@ $3.52, valued at
$1.2k
Bought 11,657 shares
@ $3.4028, valued at
$39.7k
|
|
06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/31/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 20,000 shares
@ $3.2942, valued at
$65.9k
|
|
12/26/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 5,000 shares
@ $4.4, valued at
$22k
Bought 5,000 shares
@ $4.39, valued at
$22k
|
|
12/14/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Gifted 10,000 shares
@ $0 Granted 250,000 options to buy
@ $5.94, valued at
$1.5M
|
|
12/10/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 5,000 shares
@ $5.9868, valued at
$29.9k
|
|
12/06/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 1,502 shares
@ $5.95, valued at
$8.9k
|
|
03/12/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 100,000 shares
@ $8.5, valued at
$850k
|
|
12/15/2017 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 125,000 options to buy
@ $10.6, valued at
$1.3M
|
|
11/22/2017 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 10,000 shares
@ $10.785, valued at
$107.9k
|
|
06/13/2017 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 5,000 shares
@ $9.95, valued at
$49.8k
Bought 3,784 shares
@ $9.89, valued at
$37.4k
Bought 11,216 shares
@ $9.8239, valued at
$110.2k
Bought 2,500 shares
@ $9.75, valued at
$24.4k
Bought 2,500 shares
@ $10.14, valued at
$25.4k
|
|
12/08/2016 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc. |
05/16/2016 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 30,000 shares
@ $10, valued at
$300k
Bought 300 shares
@ $9.9367, valued at
$3k
|
|
03/29/2016 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Converted 266,310 shares
@ $0 Converted 62,455 shares
@ $0 Converted 266,310 preferred shares
@ $0 Converted 62,455 preferred shares
@ $0 |
|
|
|
|